Sgi News 02
SPRIM Global Investments names Susan Dallabrida as Chief Executive Officer of SPRIM Consultancy
Post Hero
BAC and Blade Announce Definitive Merger Agreement
Sgi Portfolio Logo Aumbiosciences
AUM Biosciences announces closing of $27 million in a “Series A” Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies
Leveraging Next Gen Tools In Rare Disease Research
Leveraging Next-Gen Tools in Rare Disease Research
Sgi Portfolio Logo Fibronostics
Fibronostics Raises $8 Million in Series A Financing
The Critical Need For Virtual Covid 19 Clinical Trials And Patient Training
The Critical Need for Virtual COVID-19 Clinical Trials and Patient Training
Obviohealth And Hôpital Paris Saint Joseph Announce Partnership To Track Covid 19 In Oncology Patients
ObvioHealth and Hôpital Paris Saint-Joseph Announce Partnership to Track COVID-19 in Oncology Patients
Travecta Therapeutics Announces It Has Closed Its Oversubscribed Series A Round At $27 Million
Travecta Therapeutics Announces it has Closed its Oversubscribed Series A Round at $27 Million
Sprim Partners With Health Catalyst To Analyze Covid 19 Impact On Nash And Nafld
SPRIM Partners with Health Catalyst to Analyze COVID-19 Impact on NASH and NAFLD
Sgi Portfolio Logo Obviohealth
ObvioHealth Secures $17 Million in Latest Investment Round